X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
clinical trials (4) 4
african trypanosomiasis (2) 2
children (2) 2
drug therapy (2) 2
mortality (2) 2
parasitic diseases (2) 2
sleeping sickness (2) 2
abridged index medicus (1) 1
adolescent (1) 1
adult (1) 1
articles and commentaries (1) 1
blood (1) 1
brucei (1) 1
cerebrospinal fluid (1) 1
chagas-disease (1) 1
child (1) 1
child, preschool (1) 1
clinical-trial (1) 1
cohort studies (1) 1
democratic republic of congo (1) 1
democratic republic of the congo (1) 1
drug (1) 1
drug dosages (1) 1
drug therapy, combination (1) 1
drugs (1) 1
eflornithine - adverse effects (1) 1
eflornithine - therapeutic use (1) 1
evidence-based medicine (1) 1
failure (1) 1
female (1) 1
follow-up studies (1) 1
hats (1) 1
headache (1) 1
hospitals (1) 1
human african trypanosomiasis (1) 1
humans (1) 1
immunology (1) 1
infant (1) 1
infectious diseases (1) 1
lymphatic system (1) 1
male (1) 1
medical treatment (1) 1
medication adherence (1) 1
medicine, general & internal (1) 1
melarsoprol (1) 1
melarsoprol treatment (1) 1
microbiology (1) 1
middle aged (1) 1
nect (1) 1
nifurtimox - adverse effects (1) 1
nifurtimox - therapeutic use (1) 1
parasites (1) 1
patient safety (1) 1
pharmacology (1) 1
pharmacovigilance (1) 1
relapse (1) 1
risk factors (1) 1
risk-factors (1) 1
safety (1) 1
side effects (1) 1
studies (1) 1
treatment outcome (1) 1
tropical diseases (1) 1
trypanosoma brucei gambiense (1) 1
trypanosome (1) 1
trypanosomiasis, african - drug therapy (1) 1
uganda (1) 1
vector-borne diseases (1) 1
vomiting (1) 1
young adult (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical infectious diseases, ISSN 1058-4838, 01/2013, Volume 56, Issue 2, p. 195
  Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited. The recent development of nifurtimox-eflornithine combination... 
Parasitic diseases | Medical treatment | Clinical trials | Patient safety | Pharmacology | Drug therapy
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 01/2013, Volume 56, Issue 2, pp. 195 - 195
Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited. The recent development of nifurtimox-eflornithine combination... 
Side effects | Hospitals | Mortality | Clinical trials | Children
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.